載入...
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
BACKGROUND: Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipients. However, long-term use of calcineurin inhibitors is associated with a higher risk of chronic renal failure, neurotoxicity, de novo malignancies, recurrence of hepatitis C viral (HCV)...
Na minha lista:
發表在: | Trials |
---|---|
Main Authors: | , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4384314/ https://ncbi.nlm.nih.gov/pubmed/25873064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0626-0 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|